Name
Warp Speed: Biopharma’s Response to a Pandemic
Date & Time
Monday, October 5, 2020, 9:45 AM - 10:15 AM
Sonia Robinson Dr. Mike Ybarra
Description

In a recent statement from PhRMA, Pharmaceutical Research and Manufacturers of America, president and CEO, Stephen Ubl addressed the industry's commitment to ensuring the highest standards of research, clinical testing, and manufacturing are upheld throughout COVID-19 vaccine research and development. Our industry has responded rapidly to a pandemic and this timely fireside chat sets the stage for a week of engaging and enlightening topics. Join our executive director, Sonia Robinson and vice president and chief of medical affairs at PhRMA, Dr. Mike Ybarra with an in depth discussion on the topic that has consumed mainstream media and our daily conversations - COVID-19 vaccines and therapeutics - as well as how our industry was equipped to respond. 

You are invited to a Zoom webinar.

When: Oct 5, 2020 09:00 AM Central Time (US and Canada)

Topic: Welcome + Warp Speed Webinar

 

Please click the link below to join the webinar:

https://us02web.zoom.us/j/83279266380

Or iPhone one-tap :

    US: +13017158592,,83279266380#  or +13126266799,,83279266380#

Or Telephone:

    Dial(for higher quality, dial a number based on your current location):

        US: +1 301 715 8592  or +1 312 626 6799  or +1 929 205 6099  or +1 253 215 8782  or +1 346 248 7799  or +1 669 900 6833

Webinar ID: 832 7926 6380

    International numbers available: https://us02web.zoom.us/u/kboRSkkUP

 

Virtual Session Link
Session Description

In a recent statement from PhRMA, Pharmaceutical Research and Manufacturers of America, president and CEO, Stephen Ubl addressed the industry's commitment to ensuring the highest standards of research, clinical testing, and manufacturing are upheld throughout COVID-19 vaccine research and development. Our industry has responded rapidly to a pandemic and this timely fireside chat sets the stage for a week of engaging and enlightening topics. Join our executive director, Sonia Robinson and vice president and chief of medical affairs at PhRMA, Dr. Mike Ybarra with an in depth discussion on the topic that has consumed mainstream media and our daily conversations - COVID-19 vaccines and therapeutics - as well as how our industry was equipped to respond.